YPL162C is a gene encoding a vacuolar membrane protein in S. cerevisiae, annotated as a multi-pass transmembrane protein localized to the vacuole membrane . The antibody (UniProt ID: Q12042) binds specifically to this protein, enabling its detection in assays such as Western blotting (WB), immunofluorescence (IF), and immunoprecipitation (IP) .
| Property | Detail |
|---|---|
| Target Name | YPL162C |
| UniProt ID | Q12042 |
| Species Reactivity | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) |
| Subcellular Localization | Vacuole membrane |
| Applications | WB, IF, IP |
YPL162C is implicated in vacuolar function, though its precise role remains under investigation. Studies suggest involvement in stress response pathways, particularly the unfolded protein response (UPR). For example, ribosome ubiquitination during UPR has been linked to translational regulation of stress-response genes, though direct evidence for YPL162C’s role in this process is limited .
Translational Regulation: A 2020 bioRxiv study identified YPL162C in screens for genes affected by ribosomal protein ubiquitination during ER stress. The eS7A-4KR mutant (a ribosome-associated protein) showed diminished downregulation of HNT1 mRNA, hinting at broader regulatory networks involving vacuolar proteins .
Antibody Validation: The YPL162C antibody has been used to confirm protein expression levels in yeast strains under varying stress conditions .
Monoclonal and polyclonal antibodies like YPL162C are critical tools for studying yeast cell biology. Advances in phage display and recombinant protein expression have enhanced antibody specificity and affinity, enabling precise target detection . The YPL162C antibody exemplifies these advancements, offering researchers a reliable reagent for probing vacuolar membrane dynamics .
Further studies are needed to clarify YPL162C’s role in organelle biogenesis and stress adaptation. Coupling the antibody with CRISPR-edited yeast strains or proteomic approaches could unravel its interactome and regulatory mechanisms .
KEGG: sce:YPL162C
STRING: 4932.YPL162C
YPL162C encodes a vacuolar membrane protein in Saccharomyces cerevisiae (baker's yeast), specifically characterized as a multi-pass transmembrane protein localized to the vacuole membrane. While its precise role remains under active investigation, research indicates potential involvement in stress response pathways, particularly the unfolded protein response (UPR). Studies suggest a connection between YPL162C and translational regulation during ER stress, as it has been identified in screens for genes affected by ribosomal protein ubiquitination.
Commercial YPL162C antibodies have been validated for multiple experimental applications:
| Application | Description | Technical Considerations |
|---|---|---|
| Western Blotting (WB) | Protein expression quantification | Typically requires 20-50μg total protein per lane |
| Immunofluorescence (IF) | Subcellular localization studies | Often used with vacuolar membrane markers for co-localization |
| Immunoprecipitation (IP) | Protein-protein interaction analysis | Can identify interaction partners in stress conditions |
| ELISA | Quantitative protein detection | Enables precise measurement of expression levels |
These applications enable comprehensive investigation of YPL162C expression, localization, and interactions under various experimental conditions .
Rigorous validation of YPL162C antibodies involves multiple complementary approaches:
Genetic validation: Testing antibody reactivity in wild-type versus YPL162C knockout strains
Peptide competition assays: Demonstrating blocked antibody binding when pre-incubated with immunizing peptide
Mass spectrometry confirmation: Identifying immunoprecipitated proteins to confirm correct target binding
Cross-reactivity assessment: Testing against related proteins to ensure specific recognition
Multiple detection methods: Confirming consistent target recognition across different applications (WB, IF, IP)
Optimal Western blotting protocols for YPL162C detection should include:
Sample preparation:
Use specialized yeast lysis buffers containing protease inhibitors
Include appropriate detergents (0.5-1% Triton X-100) to solubilize membrane proteins
Electrophoresis and transfer:
10-12% SDS-PAGE gels for optimal resolution
Wet transfer to PVDF membranes at lower voltage (30V) overnight for efficient transfer of membrane proteins
Antibody incubation:
Block with 5% non-fat milk or BSA in TBST for 1 hour
Primary antibody dilution: 1:1000-1:2000, incubated overnight at 4°C
Extensive washing (4-5 times) between antibody incubations
Secondary antibody: 1:5000 HRP-conjugated anti-rabbit IgG
Controls:
For accurate subcellular localization of YPL162C using immunofluorescence:
Cell preparation:
Create spheroplasts using zymolyase (100T, 5μg/ml) in sorbitol buffer
Fix with 4% paraformaldehyde for 15 minutes
Permeabilize with 0.1% Triton X-100 for 5 minutes
Antibody staining:
Block with 3% BSA in PBS for 30 minutes
Apply YPL162C primary antibody (1:200 dilution) for 2 hours or overnight
Use fluorophore-conjugated secondary antibodies (1:500)
Include DAPI for nuclear counterstaining
Critical controls:
Co-stain with established vacuolar membrane markers (e.g., FM4-64)
Include YPL162C knockout cells as negative controls
Perform peptide competition controls
Imaging considerations:
Use confocal microscopy for precise membrane localization
Acquire Z-stacks to properly visualize entire vacuolar structures
Apply appropriate deconvolution algorithms for membrane signal enhancement
To effectively study YPL162C expression under stress conditions:
Stress induction protocols:
ER stress: DTT (2-5mM) or tunicamycin (1-5μg/ml) for 1-4 hours
Oxidative stress: H₂O₂ (0.5-2mM) for 30-60 minutes
Heat shock: 37-42°C for 15-60 minutes
Nutrient deprivation: Transfer to minimal media for 1-24 hours
Expression analysis methods:
Time-course Western blotting to track expression changes
qRT-PCR for transcriptional analysis
Fluorescence microscopy to monitor localization changes
Data analysis approaches:
Quantify band intensity relative to unstressed controls
Normalize to housekeeping proteins unaffected by stress
Perform statistical analysis across biological replicates
Advanced considerations:
Combine with phospho-specific antibodies to detect stress-induced post-translational modifications
Perform co-immunoprecipitation to identify stress-specific interaction partners
To investigate YPL162C's involvement in unfolded protein response:
UPR induction and monitoring:
Induce UPR with tunicamycin (1-5μg/ml) or DTT (2mM)
Monitor canonical UPR markers (HAC1 splicing, KAR2 upregulation)
Track YPL162C protein levels via Western blotting during UPR
Integration with ribosomal studies:
Investigate relationship between YPL162C and ribosomal protein ubiquitination
Analyze translation efficiency of stress-response mRNAs in YPL162C mutants
Perform polysome profiling to assess translational impacts
Advanced techniques:
Chromatin immunoprecipitation to identify potential transcriptional roles
Ribosome profiling to assess translational regulation
CRISPR-edited yeast strains with tagged YPL162C to track real-time dynamics
Proteomics analysis of YPL162C interactome during normal vs. stress conditions
For studying post-translational modifications of YPL162C:
Phosphorylation analysis:
Phos-tag SDS-PAGE for mobility shift detection
Phospho-specific antibodies against predicted phosphorylation sites
Mass spectrometry following immunoprecipitation
Phosphatase treatment to confirm phosphorylation status
Ubiquitination studies:
Immunoprecipitation under denaturing conditions
Probing with anti-ubiquitin antibodies
Expression of His-tagged ubiquitin for pulldown experiments
Other modifications:
Glycosylation analysis using glycosidase treatments
SUMOylation detection via specialized antibodies
Acetylation analysis through acetylation-specific antibodies
Functional correlation:
To ensure specificity when studying YPL162C:
Epitope mapping strategies:
Use peptide arrays to precisely map antibody binding sites
Develop antibodies against unique regions that don't exist in homologous proteins
Select antibodies that recognize non-conserved epitopes
Cross-reactivity testing:
Test antibodies against recombinant homologous proteins
Perform immunoprecipitation followed by mass spectrometry to identify all bound proteins
Include controls lacking YPL162C but expressing homologs
Genetic approaches:
Create epitope-tagged versions of YPL162C and homologs
Use CRISPR-Cas9 to introduce specific mutations or tags
Employ knockout strains as negative controls
Computational analysis:
When experiencing weak or absent signals:
Sample preparation optimization:
Ensure complete lysis of yeast cells (verify microscopically)
Use specialized membrane protein extraction buffers
Include protease inhibitor cocktails to prevent degradation
Avoid extended sample storage or multiple freeze-thaw cycles
Technical adjustments:
Increase protein loading (40-80μg per lane)
Optimize primary antibody concentration (try 1:500 or more concentrated)
Extend primary antibody incubation (overnight at 4°C)
Use enhanced chemiluminescence substrate with higher sensitivity
Increase exposure time incrementally
Signal enhancement techniques:
To address discrepancies between detection methods:
Methodological differences analysis:
Compare epitope accessibility in different techniques
Assess denaturing conditions that may alter antibody recognition
Consider fixation effects on epitope structure
Evaluate whether secondary antibodies perform differently across methods
Validation approaches:
Perform epitope mapping to understand binding requirements
Use multiple antibodies targeting different regions of YPL162C
Include comprehensive positive and negative controls
Confirm results with orthogonal, non-antibody techniques
Systematic troubleshooting:
To differentiate phosphorylation states:
Biochemical approaches:
Lambda phosphatase treatment to remove phosphate groups
Phos-tag SDS-PAGE for mobility shift detection
2D gel electrophoresis to separate based on charge differences
Generate and validate phospho-specific antibodies
Mass spectrometry analysis:
Immunoprecipitate YPL162C and perform phospho-peptide enrichment
Use targeted MS approaches to quantify specific phosphorylation sites
Compare phosphorylation patterns across different conditions
Functional studies:
Create phosphomimetic (S/T→D/E) and phospho-null (S/T→A) mutants
Compare phenotypes between wild-type and phospho-mutants
Assess interaction profiles of different phospho-forms
Data interpretation considerations:
Autoantibody research methodologies can enhance YPL162C studies:
Epitope mapping applications:
Use phage-displayed peptide libraries to identify immunodominant epitopes
Apply peptide arrays with overlapping residues to map linear epitopes
Identify conformational epitopes using constrained peptide libraries
Structural insights:
Autoantibodies can be used to probe protein conformation
Competition assays can map binding domains and functional regions
Compare epitope recognition between different experimental conditions
Translational research potential:
Current limitations and future directions include:
Technological limitations:
Limited epitope mapping data for commercial antibodies
Variable performance across different experimental conditions
Incomplete characterization of post-translational modifications
Emerging approaches:
Single-domain antibodies for improved access to membrane protein epitopes
CRISPR-engineered endogenous tagging for improved detection
Native mass spectrometry for intact protein complex analysis
Advanced imaging techniques for real-time protein dynamics
Future research priorities: